BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 22411819)

  • 1. Evidence for type II cells as cells of origin of K-Ras-induced distal lung adenocarcinoma.
    Xu X; Rock JR; Lu Y; Futtner C; Schwab B; Guinney J; Hogan BL; Onaitis MW
    Proc Natl Acad Sci U S A; 2012 Mar; 109(13):4910-5. PubMed ID: 22411819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple cells-of-origin of mutant K-Ras-induced mouse lung adenocarcinoma.
    Sutherland KD; Song JY; Kwon MC; Proost N; Zevenhoven J; Berns A
    Proc Natl Acad Sci U S A; 2014 Apr; 111(13):4952-7. PubMed ID: 24586047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of cancer initiating cells in K-Ras driven lung adenocarcinoma.
    Mainardi S; Mijimolle N; Francoz S; Vicente-Dueñas C; Sánchez-García I; Barbacid M
    Proc Natl Acad Sci U S A; 2014 Jan; 111(1):255-60. PubMed ID: 24367082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cell of origin and subtype of K-Ras-induced lung tumors are modified by Notch and Sox2.
    Xu X; Huang L; Futtner C; Schwab B; Rampersad RR; Lu Y; Sporn TA; Hogan BL; Onaitis MW
    Genes Dev; 2014 Sep; 28(17):1929-39. PubMed ID: 25184679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of tumorigenic cells in Kras(G12D)-induced lung adenocarcinoma.
    Cho HC; Lai CY; Shao LE; Yu J
    Cancer Res; 2011 Dec; 71(23):7250-8. PubMed ID: 22088965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the cell of origin and propagation potential of the fibroblast growth factor 9-induced mouse model of lung adenocarcinoma.
    Arai D; Hegab AE; Soejima K; Kuroda A; Ishioka K; Yasuda H; Naoki K; Shizuko K; Hamamoto J; Yin Y; Ornitz DM; Betsuyaku T
    J Pathol; 2015 Mar; 235(4):593-605. PubMed ID: 25413587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promotion of lung carcinogenesis by chronic obstructive pulmonary disease-like airway inflammation in a K-ras-induced mouse model.
    Moghaddam SJ; Li H; Cho SN; Dishop MK; Wistuba II; Ji L; Kurie JM; Dickey BF; Demayo FJ
    Am J Respir Cell Mol Biol; 2009 Apr; 40(4):443-53. PubMed ID: 18927348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciliated adenocarcinomas of the lung: a tumor of non-terminal respiratory unit origin.
    Park WY; Kim MH; Shin DH; Lee JH; Choi KU; Kim JY; Park DY; Lee CH; Sol MY
    Mod Pathol; 2012 Sep; 25(9):1265-74. PubMed ID: 22555174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of bronchioalveolar stem cells in normal lung and lung cancer.
    Kim CF; Jackson EL; Woolfenden AE; Lawrence S; Babar I; Vogel S; Crowley D; Bronson RT; Jacks T
    Cell; 2005 Jun; 121(6):823-35. PubMed ID: 15960971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid induction of lung adenocarcinoma by fibroblast growth factor 9 signaling through FGF receptor 3.
    Yin Y; Betsuyaku T; Garbow JR; Miao J; Govindan R; Ornitz DM
    Cancer Res; 2013 Sep; 73(18):5730-41. PubMed ID: 23867472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analysis of Clara cell secretory protein expression in a transgenic model of mouse lung carcinogenesis.
    Hicks SM; Vassallo JD; Dieter MZ; Lewis CL; Whiteley LO; Fix AS; Lehman-McKeeman LD
    Toxicology; 2003 May; 187(2-3):217-28. PubMed ID: 12699910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.
    Jackson EL; Willis N; Mercer K; Bronson RT; Crowley D; Montoya R; Jacks T; Tuveson DA
    Genes Dev; 2001 Dec; 15(24):3243-8. PubMed ID: 11751630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. K-ras 4A and 4B mRNA levels correlate with superoxide in lung adenocarcinoma cells, while at the protein level, only mutant K-ras 4A protein correlates with superoxide.
    Calvert RJ; Gupta M; Maciag A; Shiao YH; Anderson LM
    Lung Cancer; 2013 Jun; 80(3):263-9. PubMed ID: 23474128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caveolin-1 promotes the tumor suppressor properties of oncogene-induced cellular senescence.
    Volonte D; Vyas AR; Chen C; Dacic S; Stabile LP; Kurland BF; Abberbock SR; Burns TF; Herman JG; Di YP; Galbiati F
    J Biol Chem; 2018 Feb; 293(5):1794-1809. PubMed ID: 29247004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated Notch1 induces lung adenomas in mice and cooperates with Myc in the generation of lung adenocarcinoma.
    Allen TD; Rodriguez EM; Jones KD; Bishop JM
    Cancer Res; 2011 Sep; 71(18):6010-8. PubMed ID: 21803744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein Kinase Cι and Wnt/β-Catenin Signaling: Alternative Pathways to Kras/Trp53-Driven Lung Adenocarcinoma.
    Yin N; Liu Y; Khoor A; Wang X; Thompson EA; Leitges M; Justilien V; Weems C; Murray NR; Fields AP
    Cancer Cell; 2019 Aug; 36(2):156-167.e7. PubMed ID: 31378680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid transcription factor-1-regulated microRNA-532-5p targets KRAS and MKL2 oncogenes and induces apoptosis in lung adenocarcinoma cells.
    Griesing S; Kajino T; Tai MC; Liu Z; Nakatochi M; Shimada Y; Suzuki M; Takahashi T
    Cancer Sci; 2017 Jul; 108(7):1394-1404. PubMed ID: 28474808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. K-ras p21 expression and activity in lung and lung tumors.
    Ramakrishna G; Sithanandam G; Cheng RY; Fornwald LW; Smith GT; Diwan BA; Anderson LM
    Exp Lung Res; 2000 Dec; 26(8):659-71. PubMed ID: 11195463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling K-Ras-driven lung adenocarcinoma in mice: preclinical validation of therapeutic targets.
    Drosten M; Barbacid M
    J Mol Med (Berl); 2016 Feb; 94(2):121-35. PubMed ID: 26526121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem cell expansion.
    Dovey JS; Zacharek SJ; Kim CF; Lees JA
    Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11857-62. PubMed ID: 18697930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.